Anticancer drug candidate CBL0137, which inhibits histone chaperone FACT, is efficacious in preclinical orthotopic models of temozolomide-responsive and -resistant glioblastoma.
about
β-Elemene Selectively Inhibits the Proliferation of Glioma Stem-Like Cells Through the Downregulation of Notch1.TRAIN (Transcription of Repeats Activates INterferon) in response to chromatin destabilization induced by small molecules in mammalian cells.Glioblastoma Treatments: An Account of Recent Industrial DevelopmentsEpigenetic Targeting of GlioblastomaMechanism of FACT removal from transcribed genes by anticancer drugs curaxins
P2860
Anticancer drug candidate CBL0137, which inhibits histone chaperone FACT, is efficacious in preclinical orthotopic models of temozolomide-responsive and -resistant glioblastoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Anticancer drug candidate CBL0 ...... e and -resistant glioblastoma.
@en
Anticancer drug candidate CBL0 ...... e and -resistant glioblastoma.
@nl
type
label
Anticancer drug candidate CBL0 ...... e and -resistant glioblastoma.
@en
Anticancer drug candidate CBL0 ...... e and -resistant glioblastoma.
@nl
prefLabel
Anticancer drug candidate CBL0 ...... e and -resistant glioblastoma.
@en
Anticancer drug candidate CBL0 ...... e and -resistant glioblastoma.
@nl
P2093
P2860
P356
P1433
P1476
Anticancer drug candidate CBL0 ...... e and -resistant glioblastoma.
@en
P2093
Alfiya Safina
Andrei A Purmal
Andrei V Gudkov
Catherine A Burkhart
Gary Haderski
Katerina V Gurova
Robert J Plunkett
Tara A Barone
P2860
P304
P356
10.1093/NEUONC/NOW141
P577
2016-07-01T00:00:00Z